ICURA

iCura Diagnostics, Inc

@icura_diagnostics

Malvern, Pennsylvania
http://www.icuradx.com
Biotechnology Research

Overview

About iCura Diagnostics, Inc

Welcome to the cutting edge of spatial biology and translational research!

We're a specialized Contract Research Organization (CRO) and a CLIA High Complexity-certified, CAP-accredited clinical diagnostic laboratory, dedicated to empowering your scientific pursuits!

Our focus lies in the field of spatial biology, spatial phenotyping, tumor micro-environment mapping, multiplex immunofluorescence (mIF), IHC, histology, digital pathology, digital and quantitative PCR (dPCR and qPCR), as well as next-generation sequencing (NGS).

We use cutting-edge equipment to provide next-generation tissue pathology services, including high-resolution imaging and comprehensive analysis of tissue samples. Our collaborators include scientific teams across the drug development pipeline.
Whether you're trying to identify predictive biomarkers or stratify patients, we can help you study the intricate interplay between cells and their surroundings, unlock insights into disease mechanisms, and uncover novel targets.
Our team of experts can provide you with end-to-end support including method development and validation, sample testing, regulatory compliance, and clinical trial logistics.

Headquarters

Malvern, Pennsylvania

Website

http://www.icuradx.com

Company Size

2-10 employees

Industry

Biotechnology Research

Company Type

Partnership

Founded

2025

Specialties

Circulating Tumor Cells, Digital Pathology, Multiplexing IHC/IF, Spatial Multi-Omics, Genomics, Organoids, Spatial Biology, and AI in Digital Pathology

Posts